INSULIN RESISTANCE AND A RISK FOR POOR OUTCOME ONE YEAR AFTER MYOCARDIAL INFARCTION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The prognostic role of insulin resistance is studied in patients with myocardial infarction and a mathematical model to predict a risk of a poor outcome in individuals is presented.

Full Text

Restricted Access

About the authors

O. Gruzdeva

Research Institute for Complex Problems of Cardiovascular Diseases

Email: gruzov@cardio.kem.ru

V. Karetnikova

Research Institute for Complex Problems of Cardiovascular Diseases

E. Uchasova

Research Institute for Complex Problems of Cardiovascular Diseases

A. Kuzmina

Research Institute for Complex Problems of Cardiovascular Diseases

V. Kashtalap

Research Institute for Complex Problems of Cardiovascular Diseases

O. Barbarash

Research Institute for Complex Problems of Cardiovascular Diseases

References

  1. Rydén L., Grant P., Anker S. et al. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention // Eur. J. Anaesthesiol. - 2009; 26: 856-62.
  2. Sattar N. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now? // Minerva Endocrinol. - 2005; 3 (3): 121-38.
  3. Cefalu W. Exp. Insulin resistance: cellular and clinical concepts // Biol. Med. - 2001; 226: 13-26.
  4. Collet J., Montalescot G., Vicaut E. et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality // Circulation. - 2003; 108: 391-4.
  5. Gruzdeva O., Uchasova E., Belik E. et al. Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance // BMC Cardiovasc. Disord. - 2014; 14: 7.
  6. Барбараш О.Л., Груздева О.В., Акбашева О.Е. и др. Манифестация сахарного диабета второго типа как позднее осложнение инфаркта миокарда // Рос. кардиол. журн. - 2014; 3 (107): 87-94.
  7. De Fronzo R., Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention // Diabetes Care. - 2011; 34 (2): 202-29.
  8. Каретникова В.Н. Маркеры неблагоприятного прогноза у больных острым инфарктом миокарда с подъемом сегмента ST в сочетании с нарушениями углеводного обмена. Автореф. дис.. д-ра мед. наук. Кемерово, 2010.
  9. Katz A., Nambi S., Mather K. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans // J. Clin. Endocrinol. Metab. - 2000; 85: 2402-10.
  10. Stubbs P., Alaghband-Zadeh J., Laycock J. Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes // Heart. - 1999; 82 (4): 443-7.
  11. Garcia R., Rincön M., Arenas W. et al. Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction // Int. J. Cardiol. - 2011; 148 (1): 85-90.
  12. Grossman A., Opie L., Beshansky J. et al. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart // Circulation. - 2013; 127 (9): 1040-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Russkiy Vrach Publishing House